Naratuximab Biosimilar - Anti-CD37 Antibody - BSA and Azide free
Description du produit
Recombinant chimeric monoclonal antibody to CD37.
Applications
Flow Cytometry
Recommander des dilutions
Flow Cytometry: 1:100
Reactivité
Human
Hôte
Chimeric
Clonalité
Monoclonal
Isotype
IgG1
Conjuguer
Unconjugated
Purification
Affinity chromatography.
Concentration
Reconstitution dependent.
Forme du produit
Lyophilized
Reconstitution
Reconstitute with distilled sterile water.
Formulation
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Stockage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Notes générales
Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.
HEK293 cell line transfected with irrelevant protein (B) and human CD37 (A) were surface stained with Anti-CD37 Chimeric Antibody [Naratuximab Biosimilar] - Azide free (A318910) at 1 µg/ml followed by Anti-Human IgG Antibody (Alexa 488).
Produits alternatifs à Anti-CD37 Anticorps (A318910)